Access Bio said on Tuesday that it secured a new equity stake in CuraPatients, a U.S. digital population health-based company, to accelerate its entry into the American digital healthcare sector.Access Bio is a Kosdaq-listed U.S. company developing next-generation diagnostic kits in which Korean pha
Lunit's artificial intelligence (AI) diagnostic assistant solution draws the industry's attention by being used for the final breast cancer diagnosis in Europe.Industry executives are watching with interest whether Lunit's AI solution can become part of the screening system in Europe, where there is
Kai Health, a fertility AI company, said on Friday that it obtained European medical device certification for its embryo analysis AI solution, Eve.Accordingly, the CE certification allows Kai Health to sell Eve to countries in the European Union and other countries that acknowledge the CE certificat
LabGenomics said it would participate in the Cancer Moonshot Initiative project, which aims to reduce the death rate from cancer by more than 50 percent over the next 25 years, pushed by the Joe Biden administration.LabGenomics stressed that it is the only Korean company offering cancer diagnostic s
Lunit said it has signed a distribution agreement with Guardant Health, a U.S.-based company specializing in precision oncology, to distribute the latter’s cancer diagnostic products in Korea.Under the accord, the two companies will work to introduce Guardant Health's various liquid biopsy and tissu
Samjin Pharmaceutical announced on Wednesday that Wellysis has obtained U.S. FDA approval for S-Patch Ex, a wearable electrocardiogram (ECG) monitor.S-Patch Ex has been developed by Wellysis, a digital healthcare startup that spun off from Samsung SDS in 2019. In the Korean market, Samjin Pharmaceut
Korean digital therapeutics (DTx) makers have not made a single license application since April, according to the regulatory agency.Noting that the Nos. 1 and 2 DTx had debuted in the domestic market, industry insiders predicted that it would likely take a considerable time for the No. 3 DTx to get
Urology experts highlighted the benefits of Boston Scientific’s Rezum system as a safe incision-less, implant-free, and local anesthesia procedure with proven efficacy compared to other procedures such as transurethral resection of the prostate (TURP).Boston Scientific held a press conference to com
Neurophet said that Roche Diagnostics and global innovation platform Plug and Play have selected it as the first Korean company to participate in Startup Creasphere APAC 2023, a global startup innovation program.Startup Creasphere APAC 2023 is one of the world's largest innovation platforms for digi
EONE-Diagnomics Genome Center (EDGC), a company specializing in genomic analysis and precision medicine, said that it launched its liquid biopsy business in Vietnam in collaboration with CHEK Genomics.In June, EDGC signed a business agreement with CHEK Genomics, a leading genetics diagnostics compan
H·ROBOTICS, a robotics-based healthcare company that attracts the rehabilitation medical equipment industry’s attention, will showcase its flagship products at the K-HOSPITAL HEALTH TECH FAIR 2023 (KHF 2023), at COEX from Sept. 14 to 16.The company said Friday that it would exhibit its two mainstay
With the emerging importance of language learning models (LLM) across various industries including the healthcare industry, Google Cloud and Kakao Healthcare representatives elaborated on its collaboration to use federated learning in healthcare and life sciences.Federated learning is a machine lear
Corentec, a company specializing in the production of artificial joints, announced on Tuesday that the inaugural surgery involving its patient-specific implant (PSI) designed for artificial shoulder joints was effectively carried out at Kyungpook National University Hospital in Korea.The PSI serves
HLB Panagene said it has been recognized as a member of Cancer X, a public-private partnership aimed at conquering cancer, in recognition of its technology for molecular diagnosis of cancer using artificial genetic material.Cancer X is spearheaded by the Moffitt Cancer Center, a prominent U.S. cance
It has been confirmed that Medtronic Korea is conducting a manufacturer's recall of its laryngoscope blade, McGRATH MAC 2-Blade, from domestic medical institutions.According to the Ministry of Food and Drug Safety (MFDS), Medtronic Korea is recalling 500 units with specific manufacturing numbers. Un
Lunit plans to raise 200 billion won ($151 million) in shareholder rights offering. Aside from strengthening research and development, the company has announced the planned establishment of a corporate venture capital (CVC).In a public filing Wednesday, Lunit announced its decision to conduct a capi
Lunit has unveiled its ambitions to transition from an AI-backed medical imaging company to a big data healthcare platform provider and become profitable by 2025 through such businesses.The company held its 10th-anniversary press conference at its headquarters in Gangnam-gu, Seoul, on Thursday, wher
The Ministry of Food and Drug Safety (MFDS) has designated HeartMedi, AiMEDiC’s cardiovascular risk assessment software that evaluates the degree of stenosis of coronary arteries, and DrNoon CKD, Mediwhale’s hospital treatment software that displays the risk of chronic kidney disease, as the 41st an
Neofect, a Korean company specializing in digital rehabilitation, said on Tuesday that it signed an R&D agreement with the Korea Medical Device Development Foundation (KMDF) to apply artificial intelligence (AI) technologies to develop digital smart boards for patient rehabilitation. Neofect produce
On Monday, ATsens announced the initiation of prescriptions for its long-term continuous electrocardiogram (ECG) monitoring device, AT-Patch, in Japan. This announcement follows just one week after Huinno, another domestic ECG patch manufacturer, revealed a partnership to jointly promote its ECG pat